(S1 (S (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN c-FLIP)))) (VP (VBZ sensitizes) (NP (NN DU145) (NN prostate) (NN cancer) (NNS cells)) (PP (TO to) (NP (JJ Fas-mediated) (NN apoptosis))))) (. .)))
(S1 (S (SBAR (IN Although) (S (NP (NN DU145) (NN prostate) (NN cancer) (NNS cells)) (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (NP (ADJP (RB exogenously) (VBN applied)) (NN Fas) (NN agonist) (NN CH-11)) (PRN (-LRB- -LRB-) (NP (JJ anti-Fas) (JJ monoclonal) (NN antibody)) (-RRB- -RRB-)))))))) (, ,) (NP (NN Fas-resistance)) (VP (MD can) (VP (VB be) (VP (VBN overcome) (S (VP (VBG using) (NP (NP (DT a) (NN FasL) (NN expressing) (NN adenovirus)) (PRN (-LRB- -LRB-) (NP (NN AdGFPFasL-LRB-TET-RRB-)) (-RRB- -RRB-))))) (PRN (-LRB- -LSB-) (NP (NP (NP (NNP Hyer) (FW et) (FW al.) (, ,) (NP (JJ Molecular) (NN Therapy))) (, ,) (NP (CD 2000))) (: ;) (NP (NP (CD 2:348-58)) (PRN (-LRB- -LRB-) (NP (NN ref.12)) (-RRB- -RRB-)))) (-RRB- -RSB-))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB try) (S (VP (TO to) (VP (VB understand) (SBAR (WHADVP (WRB why)) (S (NP (NN DU145) (NNS cells)) (VP (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (NN CH-11))))) (CC and) (VP (VB determine) (NP (NP (DT the) (NN signaling) (NN pathway)) (VP (VBN utilized) (PP (IN by) (NP (NN AdGFPFasL-LRB-TET-RRB-))) (S (VP (TO to) (VP (VB induce) (NP (NN apoptosis)) (PP (IN in) (NP (DT these) (JJ Fas-resistant) (NNS cells)))))))))))))))))))) (. .)))
(S1 (S (S (VP (VBG Using) (NP (NN immunoblot) (NN analysis)))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN AdGFPFasL-LRB-TET-RRB-)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG initiating) (NP (NP (DT the) (JJ classic) (JJ Fas-mediated) (JJ apoptotic) (NN pathway)) (PP (IN in) (NP (NN DU145) (NNS cells))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ includes) (NP (NP (NP (NN activation)) (PP (IN of) (NP (NN caspases-8)))) (, ,) (NP (NP (CD -3)) (, ,) (NP (CD -7)) (, ,) (CC and) (NP (CD -9))) (, ,) (NP (NN BID) (NN cleavage)) (, ,) (NP (NP (NN cytochrome) (NN c) (NN release)) (PP (IN from) (NP (NN mitochondria)))) (, ,) (CC and) (NP (NN PARP) (NN cleavage))))))))))))))) (. .)))
(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN CH-11)) (VP (VP (VBZ binds) (PP (TO to) (NP (NN Fas)))) (, ,) (CC but) (VP (VBZ is) (ADJP (JJ unable) (S (VP (TO to) (VP (VB transmit) (NP (DT the) (NN death) (NN signal)) (PP (IN beyond) (NP (NP (DT the) (NN plasma) (NN membrane)) (VP (VBG suggesting) (NP (NP (DT a) (NN block)) (PP (IN at) (NP (NP (DT the) (NNS DISC)) (PRN (-LRB- -LRB-) (NP (NN death) (NN inducing) (NN signaling) (NN complex)) (-RRB- -RRB-)))))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (DT The) (JJ anti-apoptotic) (NN protein) (NN c-FLIP)) (PRN (-LRB- -LRB-) (NP (JJ cellular) (JJ Flice-like) (JJ inhibitory) (NN protein)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (JJ Fas-mediated) (NN apoptosis)) (PP (IN at) (NP (DT the) (NNS DISC))))))))))) (, ,)) (VP (VBD was) (VP (VBN down-regulated) (PP (VBG following) (NP (NN AdGFPFasL-LRB-TET-RRB-) (NN treatment))) (S (VP (VBG prompting) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (NP (NP (PRP$ its) (NN role)) (PP (IN in) (S (VP (VBG inhibiting) (NP (JJ CH-11-induced) (NN cell) (NN death)))))))))))))) (. .)))
(S1 (S (S (S (VP (VBG Using) (NP (NN c-FLIP) (JJ anti-sense) (NNS oligonucleotides)) (S (VP (TO to) (VP (VB down-regulate) (NP (NN c-FLIP))))))) (NP (PRP we)) (VP (VBN sensitized) (NP (NN DU145) (NNS cells)) (PP (TO to) (NP (JJ CH-11-induced) (NN apoptosis))))) (. .)))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NN c-FLIP)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (JJ Fas-mediated) (NN apoptosis)) (PP (IN in) (NP (NN prostate) (NN cancer) (NNS cells)))))))))) (CC and) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NN c-FLIP)))) (VP (MD may) (VP (VB enhance) (NP (NN Fas) (NN signaling) (NN based) (NNS therapies))))))))) (. .)))
